Cancer Center Administration provides the overall administrative services that further the research and clinical missions of the P30 support grant. Administration has been extensively reorganized to address prior critiques, and to optimize its new position in the matrix Cancer Center formed following the December 2007 merger of the formerly independent CTRC with UTHSCSA. The new Associate Director of Administration has specific responsibilities commensurate with a senior leadership position within the Cancer Center. Administration provides a variety of critical functions in support of P30 operations, including: 1) providing oversight and coordination of P30-supported programs and shared resources, 2) serving as the direct liaison for, and supporting and coordinating the functions and meetings of key scientific and oversight committees, such as the Executive Committee, the Internal Advisory Committee, the External Advisory Board, program member meetings, and scientific retreats, 3) determining policy needs, and writing and implementing those policies for programs and shared resources, 4) providing financial accounting for all P30-related activities ncluding programs, shared resources, pilot programs, seminars, retreats and other activities, 5) coordinating and documenting use of P30-related laboratory, clinical and administrative space, 6) coordinating and overseeing P30-funded personnel, 7) coordinating communications among Cancer Center investigators and leadership, and UTHSCSA personnel, 8) serving as liaison with, and coordinator for funding sources including UTHSCSA and local and national agencies, 9) working closely with the Office of Research Administration to help ensure that clinical protocols and Material Transfer Agreements are executed, documented and maintained to appropriate standards and aligned well with UTHSCSA standards, and 10) coordinating informational communications between P30-supported scientific and clinical research arms and UTHSCSA, the region and the nation. Cancer Center Administration activities do not overiap with administrative functions supported elsewhere in the CTRC or in UTHSCSA, maximizing economies of scale.

Public Health Relevance

The CTRC is in a historic period of transition and re-growth after a period of turmoil and attrition of key personnel. Administration funds are critical to maintain our ability to continue to evaluate our programmatic needs, and integration in the matrix environment. Appropriate administration helps us maintain the momentum generated by the merger and by the new leadership.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA054174-17
Application #
7944709
Study Section
Subcommittee G - Education (NCI)
Project Start
2009-08-03
Project End
2012-07-31
Budget Start
2009-08-03
Budget End
2010-07-31
Support Year
17
Fiscal Year
2009
Total Cost
$114,202
Indirect Cost
Name
University of Texas Health Science Center San Antonio
Department
Type
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Deng, Yilun; Qin, Yuejuan; Srikantan, Subramanya et al. (2018) The TMEM127 human tumor suppressor is a component of the mTORC1 lysosomal nutrient-sensing complex. Hum Mol Genet 27:1794-1808
Wei, Zhen; Panneerdoss, Subbarayalu; Timilsina, Santosh et al. (2018) Topological Characterization of Human and Mouse m5C Epitranscriptome Revealed by Bisulfite Sequencing. Int J Genomics 2018:1351964
Chiang, Huai-Chin; Zhang, Xiaowen; Zhao, Xiayan et al. (2018) Gene-Specific Genetic Complementation between Brca1 and Cobra1 During Mouse Mammary Gland Development. Sci Rep 8:2731
Zanotto-Filho, Alfeu; Rajamanickam, Subapriya; Loranc, Eva et al. (2018) Sorafenib improves alkylating therapy by blocking induced inflammation, invasion and angiogenesis in breast cancer cells. Cancer Lett 425:101-115
Donegan, Jennifer J; Boley, Angela M; Lodge, Daniel J (2018) Embryonic stem cell transplants as a therapeutic strategy in a rodent model of autism. Neuropsychopharmacology 43:1789-1798
Segovia, Jesus A; Chang, Te-Hung; Winter, Vicki T et al. (2018) NLRP3 Is a Critical Regulator of Inflammation and Innate Immune Cell Response during Mycoplasma pneumoniae Infection. Infect Immun 86:
Cepeda, Sergio; Cantu, Carolina; Orozco, Stephanie et al. (2018) Age-Associated Decline in Thymic B Cell Expression of Aire and Aire-Dependent Self-Antigens. Cell Rep 22:1276-1287
Vaidya, Anand; Flores, Shahida K; Cheng, Zi-Ming et al. (2018) EPAS1 Mutations and Paragangliomas in Cyanotic Congenital Heart Disease. N Engl J Med 378:1259-1261
Ramasamy, Kumaraguruparan; Balasubramanian, Sowmya; Manickam, Krishnan et al. (2018) Mycoplasma pneumoniae Community-Acquired Respiratory Distress Syndrome Toxin Uses a Novel KELED Sequence for Retrograde Transport and Subsequent Cytotoxicity. MBio 9:
Snead, Wilton T; Zeno, Wade F; Kago, Grace et al. (2018) BAR scaffolds drive membrane fission by crowding disordered domains. J Cell Biol :

Showing the most recent 10 out of 989 publications